Viewing Study NCT05201118


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-01-26 @ 6:48 PM
Study NCT ID: NCT05201118
Status: UNKNOWN
Last Update Posted: 2022-05-24
First Post: 2022-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
Sponsor: Chunrui Li
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extramedullary Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CT103A View
None Selinexor View